New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulc ...
Phase 3 Study to Establish the Efficacy and Safety of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium Dosed Twice Daily in Achieving Clinical Improvement in Subjects With Mildly to Moderately Active Ulcerative Colitis After 8 Weeks of Therapy Phase 3 Study to Establish the Efficacy and Safety of a New Tablet Formulation and Dosing Regimen of ...